ReAlta Life Sciences, Inc. is a mid-stage clinical biotech company headquartered in Norfolk, Virginia, dedicated to developing novel treatments for severe inflammatory and rare diseases.
Subscribe to see ReAlta Life Sciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ReAlta Life Sciences, Inc. is a company headquartered in United States. Its most recent funding round raised $40M in April 2026. Xcout tracks 16 named people at ReAlta Life Sciences, Inc., including Howard Berman (Chief Executive Officer).
10 more named people on record for ReAlta Life Sciences, Inc., with roles, board committees and tenure — see the full roster →
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $40M | — | |
| SEC Form D filing | $25M | — | |
| SEC Form D filing | $29.9M | — | |
| SEC Form D filing | $12M | — | |
| Series A3 | $20M | 1 named | |
| SEC Form D filing | $22.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ReAlta Life Sciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Areteia Therapeutics, Inc. is a clinical-stage biotechnology company located in Foxboro, Massachusetts and Chapel Hill, North Carolina, focused on developing novel inflammation therapies.
Viela Bio, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to the discovery, development, and commercialization of novel therapies for autoimmune and severe inflammatory diseases.
Halia Therapeutics, Inc. is a clinical-stage biotechnology research company focused on discovering and developing novel therapies to improve the lives of patients with inflammatory disorders and other diseases. The company is actively advancing global clinical programs and is headquartered in Lehi, Utah.
Reata Pharmaceuticals, Inc. is a pharmaceutical manufacturing company headquartered in Plano, Texas. Founded in 2002, the company investigates and develops innovative experimental therapeutics to change the treatment landscape for patients with severe, life-threatening diseases.
HemoShear Therapeutics, Inc. is a privately held clinical-stage biotechnology company located in Charlottesville, Virginia, focused on developing novel drugs for rare metabolic diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ReAlta Life Sciences, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.